CAH vs CERS · P/E 35, rev $222.58B vs rev $201.3M
Cardinal Health Inc (CAH) versus Cerus Corporation (CERS) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Cerus Corporation (CERS) is a medical devices company listed on US.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. CERS currently screens at market cap $294.4M.
Not investment advice. Open the CAH and CERS stock pages for the full models.
Not investment advice.